For example, in melanoma, CCR5 was found to induce EMT through the secretion of TGFβ1 by CCR5+ cancer cells, triggering non-canonical TGFβ-mediated activation of the PI3K/Akt/GSK3β signaling pathway [160]. This evidence concerns the gene CCR5 and melanoma.